PubRank

Barry Kiely

Author PubWeight™ 27.04‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Lactobacillus and bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles. Gastroenterology 2005 5.75
2 Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome. Am J Gastroenterol 2006 3.24
3 Commensal-induced regulatory T cells mediate protection against pathogen-stimulated NF-kappaB activation. PLoS Pathog 2008 2.21
4 Effect of broad- and narrow-spectrum antimicrobials on Clostridium difficile and microbial diversity in a model of the distal colon. Proc Natl Acad Sci U S A 2010 2.11
5 Bifidobacterium infantis 35624 administration induces Foxp3 T regulatory cells in human peripheral blood: potential role for myeloid and plasmacytoid dendritic cells. Gut 2011 1.78
6 Antimicrobial activity of lacticin 3,147 against clinical Clostridium difficile strains. J Med Microbiol 2007 1.33
7 The vexed relationship between Clostridium difficile and inflammatory bowel disease: an assessment of carriage in an outpatient setting among patients in remission. Am J Gastroenterol 2009 1.16
8 Metabolic activity of the enteric microbiota influences the fatty acid composition of murine and porcine liver and adipose tissues. Am J Clin Nutr 2009 1.15
9 Mucosal cytokine imbalance in irritable bowel syndrome. Scand J Gastroenterol 2008 1.11
10 Bifidobacterium infantis 35624 modulates host inflammatory processes beyond the gut. Gut Microbes 2013 1.01
11 Contrasting effects of Bifidobacterium breve NCIMB 702258 and Bifidobacterium breve DPC 6330 on the composition of murine brain fatty acids and gut microbiota. Am J Clin Nutr 2012 0.93
12 Bifidobacterium animalis AHC7 protects against pathogen-induced NF-κB activation in vivo. BMC Immunol 2010 0.90
13 Degradation of the extracellular matrix components by bacterial-derived metalloproteases: implications for inflammatory bowel diseases. Inflamm Bowel Dis 2010 0.88
14 Impact of administered bifidobacterium on murine host fatty acid composition. Lipids 2010 0.84
15 Bioavailability of the anti-clostridial bacteriocin thuricin CD in gastrointestinal tract. Microbiology 2013 0.82
16 Bifidobacterium breve with α-linolenic acid and linoleic acid alters fatty acid metabolism in the maternal separation model of irritable bowel syndrome. PLoS One 2012 0.82
17 Clinical benefits of probiotic canine-derived Bifidobacterium animalis strain AHC7 in dogs with acute idiopathic diarrhea. Vet Ther 2009 0.81
18 Carriage of Clostridium difficile in outpatients with irritable bowel syndrome. J Med Microbiol 2012 0.78